Chapter 10: Future Developments in Radiotherapy

References

• CEC Commission of the European Communities. Statement by the cancer research working party. Brussels. 1991, Report CAN-MED 3/8.1.
   Google Scholar
• Urtasun R C. Does improved depth dose characteristics and treatment planning correlate with a gain in therapeutic results? Evidence from past clinical experience using conventional radiation sources. Int J Radiat Oncol Biol Phys 1991; 22: 235–239
   Web of Science ®Google Scholar
• Holthusen H. Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen und deren Nutzanwendung zur Verhütung von Schäden. Strahlentherapie 1936; 57: 254–269
   Google Scholar
• Overgaard M. Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of raction size and dose-response relationships on late bone damage. Acta Oncol 1988; 27: 117–122
   PubMed Web of Science ®Google Scholar
• Radiobiologic and clinical requirements. Accuracy requirements and quality assurance of external beam therapy with photons and electrons, A Brahme, 1988; 9–15, (Suppl 1)Acta Oncol
   Google Scholar
• Thames H D, Schultheiss T E, Hendry J H, Tucker S L, Dubray B M, Brock W A. Can modest escalations of dose be detected as increased tumor control?. Int J Radiat Oncol Biol Phys 1992; 22: 241–246
   PubMed Web of Science ®Google Scholar
• Suit H S, du Bois W. The importance of optimal treatment planning in radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 1471–1478
   PubMed Web of Science ®Google Scholar
• Dobbs H J, Parker R P. The respective roles of simulator and computed tomography in radiotherapy planning: a review. Clin Radiol 1984; 35: 433–439
   PubMed Web of Science ®Google Scholar
• Rothwell R I, Ash D V, Thorogood J. An analysis of the contribution of computed tomography to the treatment outcome in bladder cancer. Clin Radiol 1985; 36: 369–372
   PubMed Web of Science ®Google Scholar
• Goitein M. The utility of computed tomography in radiation therapy: an estimate of outcome. Int J Radiat Oncol Biol Phys 1979; 5: 1799–1807
   PubMed Web of Science ®Google Scholar
• Lind B L. Radiation therapy planning and optimization studied as inverse problems (Thesis). Department of Radiation Physics, University of Stockholm, StockholmSweden 1991
   Google Scholar
• Leksell L. Stereotaxis and radiosurgery. An operative system. Charles C Tomas, Springfield, IL 1971
   Google Scholar
• Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33: 677–683
   PubMed Web of Science ®Google Scholar
• Thames H D. Early fractionation methods and the origins of the NSD concept. Acta Oncol 1988; 27: 89–103
   PubMed Web of Science ®Google Scholar
• Douglas B G, Fowler J F. The effect of multiple small doses of x-rays on skin reactions in the mouse and a basic interpretation. Rad Res 1976; 66: 401–426
   PubMed Web of Science ®Google Scholar
• Thames H D, Withers H R, Peters L J, Fletcher G H. Changes in early and late radiation resones with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8: 219–226
   PubMed Web of Science ®Google Scholar
• Horiot J C, Le Fur R, Guyen T N, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231–241
   PubMed Web of Science ®Google Scholar
• Näslund I, Nilsson B, Littbrand B. Hyperfractionated radiotherapy of bladder cancer—A ten-year follow-up of a randomized clinical trial. Acta Oncol 1994; 33: 397–402
   PubMed Web of Science ®Google Scholar
• Pigott K H, Dische S, Saunders M I. The long-term outcome after radical radiotherapy for advanced head and neck cancer. Clin Oncol 1993; 5: 343–349
   Google Scholar
• Pigott K H, Saunders M I. The long-term outcome after radical radiotherapy advanced localized non-small cell carcinoma of the lung. Clin Oncol 1993; 5: 350–354
   Google Scholar
• Bentzen S M, Overgaard J, Thames H E, Overgaard M, Vejby-Hansen H, von der Maase H, Meder J. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989; 16: 159–244
   PubMed Web of Science ®Google Scholar
• Lamwton P A. Predicting the response to radiotherapy. Clin Oncol 1993; 5: 193–194
   Google Scholar
• West C ML, Davidson S E, Hendry J H, Hunter R D. Prediction of cervical carcinoma response to radiotherapy. Lancet 1991; 338: 818
   PubMed Web of Science ®Google Scholar
• Hall E J. The gene as them in the paradigm of cancer. Br J Radiol 1993; 66: 1–11
   PubMed Web of Science ®Google Scholar
• Hodgkiss R J, Begg A C, Middleton R W, et al. Fluorescent marker for hypoxic cells. A study of novel heterocyclic compounds that undergo bioreductive binding. Biochemical Pharm 1991; 41: 533–541
   PubMed Web of Science ®Google Scholar
• Gatenby R A, Kessler H B, Rosenblum J S, et al. Oxygen distribution in squamous cell carcinoma metastasis and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988; 14: 831–838
   PubMed Web of Science ®Google Scholar
• Wambersie A, Richard F. Present status of the fast neutron therapy. Survey of the clinical data and the clinical research programmes. Coordinated Research Programme (2nd Meeting 24–27 January 1988), “Nuclear data needed for neutron therapy”. IAEA, Vienna 1989
   Google Scholar
• Acta Oncol 1994; vol 33, nr 3
   Google Scholar
• Goffman T E, Raubitschek A, Mitchell J B, Glatstein E. The emerging biology of modern radiation oncology. Cancer Res 1990; 50: 7735–7744
   PubMed Web of Science ®Google Scholar
• Hatanaka H, Amano K, Kamano S, Sano K. Clinical experience of boron neutron capture therapy of malignant brain tumors (1968–1985). Boron neutron caputre therapy, H Hatanaka. Nishimura Co Ltd, NiigataJapan 1986; 447–449
   Google Scholar
• Mishima Y, Ichihashi M, Hatta S, Honda C, Yamamura K, Nakagawa T. New thermal neutron capture thearpy for malignant melanoma: Melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial. Pigment Cell Res 1989; 2: 226–234
   PubMedGoogle Scholar
• Carlsson J, Sjöberg S, Larsson B S. Present status of boron neutron capture therapy. Acta Oncol 1992; 31: 803–813
   PubMed Web of Science ®Google Scholar
• Watson E L, Halnan K E, Dische S, et al. Hyperbaraic oxygen and radiotherapy: a medical research council trial in carcinoma of the cervix. Br J Radiol 1978; 51: 879–887
   PubMed Web of Science ®Google Scholar
• Henk J M. Late results of trial of hyperbaric oxygen and radiotherapy in head and neck cancer: Rational for hypoxic cell sensitizers?. Int J Radiat Oncol Biol Phys 1986; 12: 1339–1341
   PubMed Web of Science ®Google Scholar
• Overgaard J. Modification of tumour hypoxia. A metaanalysis of controlled clinical trials. Radioth Oncol 1992; 24, (Suppl 64)
   Google Scholar
• Kjellén E, Joiner M C, Collier J M, Johns H, Rojas A F. A therapeutic benefit from combining carbogen or oxygen with nicotinamide in fractionated x-ray treatments. Radioth Oncol 1991; 22: 81–91
   PubMed Web of Science ®Google Scholar
• Rojas A. ARCON: accelerated radiotherapy with carbogen and nicotinamide. Radiation science of molecules, mice and men. Br J Radiol, J Denekamp, D G Hirst, 1992; 174–178, Suppl 24
   Google Scholar
• Henriksson R, Franzén L, Littbrand B. Prevention of irradiation-induced bowel discomfort by sacralfate: A double-blind, placebo-controlled study when treating localized pelvic cancer. Am J Med 1991; 91(Suppl 217)151–157
   PubMed Web of Science ®Google Scholar
• Auqvier A, Rutqvist L E, Höst H, Rotstein S, Arrigada K. Post-mastectomy megavoltage radiotherapy: The Oslo and Stockholm trials. Eur J Cancer 1992; 28: 433–437
   PubMed Web of Science ®Google Scholar
• Peters L J, Goepfert H, Ang K K, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993; 26: 3–11
   PubMed Web of Science ®Google Scholar
• Pålhman L. Swedish rectal cancer trial. Br J Surg 1993; 80: 1333–1336
   PubMed Web of Science ®Google Scholar
• Calvo F A, Azinovic J, Pardo F, Hernandez J L, Alvarez-Cienfuegos J. Colorectal cancer. Intro operative radiotherapy, M Santos, L Brady. Springer Verlag, Berlin 1992; 65–72
   Google Scholar
• De Vita V T. Progress in cancer management. Cancer 1983; 51: 2401–2409
   PubMed Web of Science ®Google Scholar
• Suit H S. Potential for improving survival rates for the cancer patient by increasing efficacy of treatment of the primary lesion. Cancer 1982; 50: 1227–1234
   PubMed Web of Science ®Google Scholar
• Withers H R, Taylor J MG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–146
   PubMed Web of Science ®Google Scholar
• Tubiana M. Repopulation in human tumours. Acta Oncol 1988; 27: 83–88
   PubMed Web of Science ®Google Scholar
• Ågren Cronqvist A-K. Quantification of the response of heterogenous tumours and organized normal tissues to fractionated radiotherapy. (Thesis). Department of Medical Radiation Physics, Stockholm University, StockholmSweden 1995
   Google Scholar